NRNP 6675 MIDTERM EXAM (YEAR 2022 – 100/100 POINTS) LATEST UPDATE NRNP 6675 MIDTERM EXAM (YEAR 2022 –2023score 100/100 POINTS) LATEST UPDATE 1. Which of the following are risk factors for neuroleptic malignant syndrome? Select all that applyAge Rapid dose
NRNP 6675 MIDTERM EXAM (YEAR 2022 – 100/100 POINTS) LATEST UPDATE NRNP 6675 MIDTERM EXAM (YEAR 2022 –2023score 100/100 POINTS) LATEST UPDATE 1. Which of the following are risk factors for neuroleptic malignant syndrome? Select all that applyAge Rapid dose escalation Parental route of administration Higher potency typical antipsychotics 2. Antipsychotic medications provide D2 blockade in the mesocortical pathway causing which of thefollowing
Información del documento
- Subido en
- 8 de febrero de 2024
- Número de páginas
- 58
- Escrito en
- 2023/2024
- Tipo
- Examen
- Contiene
- Preguntas y respuestas